David Silberstein

622 total citations
15 papers, 490 citations indexed

About

David Silberstein is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, David Silberstein has authored 15 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Genetics. Recurrent topics in David Silberstein's work include Receptor Mechanisms and Signaling (4 papers), Glioma Diagnosis and Treatment (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). David Silberstein is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Glioma Diagnosis and Treatment (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). David Silberstein collaborates with scholars based in United States, United Kingdom and Taiwan. David Silberstein's co-authors include Alastair J.J. Wood, Richard P. Koshakji, Hong‐Hao Zhou, G. Wilkinson, Dan M. Roden, Raymond L. Woosley, Christian Funck‐Brentano, H K Kroemer, A J Wood and Michel Eichelbaum and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

David Silberstein

14 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Silberstein United States	7	179	134	107	60	57	15	490
Richard P. Koshakji United States	14	145 0.8×	145 1.1×	89 0.8×	36 0.6×	65 1.1×	22	594
R. E. Vestal United States	8	151 0.8×	146 1.1×	70 0.7×	73 1.2×	63 1.1×	12	607
T Douglas Cowart United States	7	108 0.6×	107 0.8×	42 0.4×	31 0.5×	50 0.9×	10	347
Johan Wemer Netherlands	15	53 0.3×	102 0.8×	103 1.0×	85 1.4×	48 0.8×	34	460
Ola Rönn Sweden	13	172 1.0×	142 1.1×	60 0.6×	29 0.5×	79 1.4×	25	545
K. Reiff United States	9	187 1.0×	98 0.7×	59 0.6×	22 0.4×	59 1.0×	16	515
Hannah Lu United States	8	204 1.1×	88 0.7×	62 0.6×	24 0.4×	75 1.3×	9	441
PR Jackson United Kingdom	11	115 0.6×	151 1.1×	51 0.5×	42 0.7×	65 1.1×	21	459
RG Shanks United Kingdom	12	243 1.4×	78 0.6×	124 1.2×	68 1.1×	34 0.6×	39	592
William Schary United States	10	63 0.4×	220 1.6×	113 1.1×	46 0.8×	89 1.6×	26	623

Countries citing papers authored by David Silberstein

Since Specialization

Citations

This map shows the geographic impact of David Silberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Silberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Silberstein more than expected).

Fields of papers citing papers by David Silberstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Silberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Silberstein. The network helps show where David Silberstein may publish in the future.

Co-authorship network of co-authors of David Silberstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Silberstein. A scholar is included among the top collaborators of David Silberstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Silberstein. David Silberstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Silberstein, David, et al.. (2025). Prenatal methadone exposure produces functional and molecular alterations in the basolateral amygdala and decreased voluntary ethanol intake in female, but not male offspring. Frontiers in Behavioral Neuroscience. 19. 1570951–1570951.

Peters, Katherine B., John L. Villano, Nicholas Butowski, et al.. (2021). Phase 2 trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.. Journal of Clinical Oncology. 39(15_suppl). TPS2069–TPS2069. 1 indexed citations

Peters, Katherine B., Adam L. Cohen, Nicholas Butowski, et al.. (2020). BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.. Journal of Clinical Oncology. 38(15_suppl). TPS2577–TPS2577. 2 indexed citations

Peters, Katherine B., John P. Kirkpatrick, Mary Lou Affronti, et al.. (2019). First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 105(1). E106–E106. 5 indexed citations

Chang, En‐Ting, David Silberstein, Mehdi Rambod, János Pórszász, & Richard Casaburi. (2011). Heart rate variability during constant work rate exercise at and above the critical power in patients with severe chronic obstructive pulmonary disease. Tzu Chi Medical Journal. 23(2). 42–45. 7 indexed citations

Ayappa, Indu, Robert G. Norman, David Whiting, et al.. (2009). Irregular Respiration as a Marker of Wakefulness During Titration of CPAP. SLEEP. 32(1). 99–104. 14 indexed citations

Silberstein, David, et al.. (1990). The Role of Genetically Determined Polymorphic Drug Metabolism in the Beta-Blockade Produced by Propafenone. New England Journal of Medicine. 322(25). 1764–1768. 91 indexed citations

Naslund, Thomas C., et al.. (1990). Low sodium intake corrects abnormality in β-receptor–mediated arterial vasodilation in patients with hypertension: Correlation with β-receptor function in vitro. Clinical Pharmacology & Therapeutics. 48(1). 87–95. 53 indexed citations

Zhou, Hong-Hao, David Silberstein, Richard P. Koshakji, & Alastair J.J. Wood. (1989). Interindividual differences in β-receptor density contribute to variability in response to β-adrenoceptor antagonists. Clinical Pharmacology & Therapeutics. 45(6). 587–592. 17 indexed citations

10.

Zhou, Hong‐Hao, Richard P. Koshakji, David Silberstein, G. Wilkinson, & Alastair J.J. Wood. (1989). Racial Differences in Drug Response. New England Journal of Medicine. 320(9). 565–570. 196 indexed citations

11.

Kroemer, H K, Christian Funck‐Brentano, David Silberstein, et al.. (1989). Stereoselective disposition and pharmacologic activity of propafenone enantiomers.. Circulation. 79(5). 1068–1076. 92 indexed citations

12.

Silberstein, David, et al.. (1989). Alteredβ-Adrenoceptor Internalization Does Not Explain Reducedβ-Adrenergic Responsiveness in the Elderly*. The Journal of Clinical Endocrinology & Metabolism. 68(1). 131–134. 3 indexed citations

13.

Silberstein, David, C J Bowmer, & M S Yates. (1988). Dibromosulphophthalein: its pharmacokinetics and binding to hepatic cytosol proteins in rats with acute renal failure. British Journal of Pharmacology. 95(2). 343–352. 2 indexed citations

14.

Silberstein, David, C J Bowmer, & M S Yates. (1987). Pharmacokinetics and biliary excretion of rose bengal in rats with acute and chronic renal failure. Journal of Pharmacy and Pharmacology. 39(5). 395–398. 3 indexed citations

15.

Silberstein, David, C J Bowmer, M S Yates, & H G Dean. (1986). Effect of acute renal failure on the disposition and elimination of [3H]N-acetyl procainamide ethobromide in the rat. Journal of Pharmacy and Pharmacology. 38(9). 679–685. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact